Ignite Creation Date:
2025-12-25 @ 3:45 AM
Ignite Modification Date:
2026-01-27 @ 4:57 AM
Study NCT ID:
NCT07107802
Status:
COMPLETED
Last Update Posted:
2025-11-28
First Post:
2025-07-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1 Single Ascending Dose Study With ATX101
Sponsor:
Aurobac Therapeutics SAS
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ATX101-CLN-1001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None